| Ryan S Worley, MD | |
|
5435 Feltl Rd, Minnetonka, MN 55343-7983 | |
| (952) 857-1504 | |
| (952) 857-1554 |
| Full Name | Ryan S Worley |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 5435 Feltl Rd, Minnetonka, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790096741 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 106962 (Minnesota) | Primary |
| Entity Name | Emergency Physicians Professional Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801871934 PECOS PAC ID: 9537072657 Enrollment ID: O20031106000068 |
News Archive
CHILDREN in the UK with a high risk form of the childhood cancer neuroblastoma are set to benefit from a new international clinical trial - funded by Cancer Research UK - which uses immunotherapy to help prevent the disease from coming back.
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of neurodegenerative disorders.
A team of researchers at CIC bioGUNE has revealed that oestrogen can reduce the risk of breast cancer. Their work shows that oestrogen is capable of reducing the number of breast cancer stem cells, which may explain the lower aggression of the tumour and, as a consequence, the possibility of a better prognosis.
AIDS Healthcare Foundation will host a protest Wednesday morning, March 24th at 10:30am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, one of the most expensive first-line AIDS treatment in the US, during the Barclays Capital Global Healthcare Conference.
OSI Pharmaceuticals, Inc. announced today its financial results for the Company's third quarter ended September 30, 2009. The Company reported total revenues from continuing operations of $111 million for the third quarter of 2009 compared to revenues of $95 million for the third quarter of 2008, an 18% increase over the prior year period.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan S Worley, MD 5435 Feltl Rd, Minnetonka, MN 55343-7983 Ph: (952) 857-1504 | Ryan S Worley, MD 5435 Feltl Rd, Minnetonka, MN 55343-7983 Ph: (952) 857-1504 |
News Archive
CHILDREN in the UK with a high risk form of the childhood cancer neuroblastoma are set to benefit from a new international clinical trial - funded by Cancer Research UK - which uses immunotherapy to help prevent the disease from coming back.
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of neurodegenerative disorders.
A team of researchers at CIC bioGUNE has revealed that oestrogen can reduce the risk of breast cancer. Their work shows that oestrogen is capable of reducing the number of breast cancer stem cells, which may explain the lower aggression of the tumour and, as a consequence, the possibility of a better prognosis.
AIDS Healthcare Foundation will host a protest Wednesday morning, March 24th at 10:30am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, one of the most expensive first-line AIDS treatment in the US, during the Barclays Capital Global Healthcare Conference.
OSI Pharmaceuticals, Inc. announced today its financial results for the Company's third quarter ended September 30, 2009. The Company reported total revenues from continuing operations of $111 million for the third quarter of 2009 compared to revenues of $95 million for the third quarter of 2008, an 18% increase over the prior year period.
› Verified 4 days ago
Dr. Kendal Farrar, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5435 Feltl Rd, Minnetonka, MN 55343 Phone: 952-835-9880 Fax: 952-857-1554 | |
Taj Melson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5435 Feltl Rd, Minnetonka, MN 55343 Phone: 952-835-9880 Fax: 952-857-1554 | |
Edgar Austria, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5435 Feltl Rd, Minnetonka, MN 55343 Phone: 952-857-1154 Fax: 952-857-1154 | |
Justin Matthew Steinberg, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5435 Feltl Rd, Minnetonka, MN 55343 Phone: 952-835-9880 Fax: 952-857-1554 | |
Arthur James Puff, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 15008 Crown Dr, Minnetonka, MN 55345 Phone: 952-933-9735 | |
Dr. Robert Anderson, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5435 Feltl Rd, Minnetonka, MN 55343 Phone: 952-835-9880 | |
Dr. Michael Steven Schwemm, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5435 Feltl Rd, C/o Eppa, Minnetonka, MN 55343 Phone: 952-835-9880 |